AU2001236678A1 - Adamantyl derivatives as anti-cancer agents - Google Patents
Adamantyl derivatives as anti-cancer agentsInfo
- Publication number
- AU2001236678A1 AU2001236678A1 AU2001236678A AU3667801A AU2001236678A1 AU 2001236678 A1 AU2001236678 A1 AU 2001236678A1 AU 2001236678 A AU2001236678 A AU 2001236678A AU 3667801 A AU3667801 A AU 3667801A AU 2001236678 A1 AU2001236678 A1 AU 2001236678A1
- Authority
- AU
- Australia
- Prior art keywords
- cancer agents
- adamantyl derivatives
- adamantyl
- derivatives
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/498,347 | 2000-02-04 | ||
US09/498,347 US6462064B1 (en) | 1996-07-08 | 2000-02-04 | Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias |
PCT/US2001/003717 WO2001056563A1 (en) | 2000-02-04 | 2001-02-05 | Adamantyl derivatives as anti-cancer agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001236678A1 true AU2001236678A1 (en) | 2001-08-14 |
Family
ID=23980692
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001236678A Abandoned AU2001236678A1 (en) | 2000-02-04 | 2001-02-05 | Adamantyl derivatives as anti-cancer agents |
Country Status (5)
Country | Link |
---|---|
US (2) | US6462064B1 (ja) |
EP (1) | EP1272176A4 (ja) |
JP (1) | JP2003521513A (ja) |
AU (1) | AU2001236678A1 (ja) |
WO (1) | WO2001056563A1 (ja) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005516908A (ja) * | 2001-11-30 | 2005-06-09 | ザ バーナム インスティチュート | 癌細胞におけるアポトーシスの誘導 |
US7449480B2 (en) * | 2002-05-14 | 2008-11-11 | Baylor College Of Medicine | Small molecule inhibitors of HER2 expression |
EP1509226A4 (en) * | 2002-05-14 | 2008-04-09 | Baylor College Medicine | SMALL MOLECULAR INHIBITORS OF THE HER2 EXPRESSION |
EP1572176A2 (en) * | 2002-12-12 | 2005-09-14 | Galderma Research & Development, S.N.C. | Aqueous-alcoholic depigmenting gel containing a phenolic derivative and a retinoid |
US6984508B2 (en) * | 2003-06-11 | 2006-01-10 | Ultra Biotech Limited | Biological compositions and methods for treatment of cervical cancer |
MX2007015679A (es) * | 2005-06-30 | 2008-02-21 | Amgen Inc | Inhibidores de quinasa bis-aril y su uso en el tratamiento de inflamacion, angiogenesis y cancer. |
US20110040115A1 (en) * | 2005-12-02 | 2011-02-17 | Finorga Sas | Intermediates and process for the preparation of aromatic derivatives of 1-adamantane |
WO2007130469A2 (en) * | 2006-05-02 | 2007-11-15 | Ordway Research Institute, Inc. | Induction of intracellular and secreted growth inhibitors and paracrine tumor-suppressive activity by rar ligands |
LV13737B (en) * | 2006-12-28 | 2008-10-20 | Vjaceslavs Tribulovics | Method for manufacturing 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid |
PT2125697T (pt) * | 2007-01-15 | 2016-10-18 | Yu Chongxi | Pró-fármacos solúveis em água positivamente carregados de retinóides e compostos tipo retinóide com taxas de penetração na pele muito altas |
US7858666B2 (en) | 2007-06-08 | 2010-12-28 | Mannkind Corporation | IRE-1α inhibitors |
JP2010539245A (ja) * | 2007-09-14 | 2010-12-16 | 日東電工株式会社 | 薬物担体 |
IN266834B (ja) * | 2008-03-17 | 2015-06-05 | Glenmark Pharmaceuticals Sa | |
KR101576235B1 (ko) * | 2012-11-30 | 2015-12-11 | 한국생명공학연구원 | 신규한 이치환 아다만틸 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 암 전이 억제용 약학적 조성물 |
US20140213651A1 (en) * | 2013-01-31 | 2014-07-31 | Biodelight Biotech Inc. | Novel Use of Adapalene in Treating Cancer |
KR102359435B1 (ko) * | 2015-03-31 | 2022-02-09 | (주)아모레퍼시픽 | 5-아다만탄-1-일-n-(2,4-다이하이드록시벤질)-2,4-다이메톡시벤즈아마이드를 함유하는 항염 조성물 |
US20170181988A1 (en) * | 2015-12-23 | 2017-06-29 | Cipla Limited | Methods for the treatment of bladder cancer |
EP3301085A1 (en) | 2016-09-29 | 2018-04-04 | Biogem S.Ca.R.L. | Retinoid derivatives with antitumor activity |
US11278025B2 (en) | 2017-05-17 | 2022-03-22 | The General Hospital Corporation | Antibiotic compounds |
WO2019018185A1 (en) | 2017-07-15 | 2019-01-24 | Arisan Therapeutics Inc. | ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS |
IT201900003343A1 (it) | 2019-03-07 | 2020-09-07 | Special Product’S Line S P A | Derivati fenolici per uso come antimicrobici, antibatterici, battericidi |
IT202000029912A1 (it) | 2020-12-04 | 2022-06-04 | Special Product’S Line S P A | Derivati fenolici per uso come antimicrobici, antibatterici, battericidi |
IT202000029906A1 (it) | 2020-12-04 | 2022-06-04 | Special Product’S Line S P A | Derivati fenolici per uso come antimicrobici, antibatterici, battericidi. |
IT202000029882A1 (it) | 2020-12-04 | 2022-06-04 | Special Product’S Line S P A | Derivati fenolici per uso come antimicrobici, antibatterici, battericidi |
WO2022229017A1 (en) | 2021-04-27 | 2022-11-03 | Biogem S.C.A R.L. | Adamantyl retinoid derivative with anticancer activity |
CN113925868A (zh) * | 2021-11-19 | 2022-01-14 | 上海市同仁医院 | 一种神经酰胺在制备抗肿瘤药物中的应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK155079A (da) | 1978-04-14 | 1979-10-15 | Sumitomo Chemical Co | Fremgangsmaade til fremstilling af tricycliske broforbindelser |
DE3026579A1 (de) | 1980-07-14 | 1982-02-11 | Kali-Chemie Pharma Gmbh, 3000 Hannover | 2,9-dioxatricyclo (4,3,1,o(pfeil hoch)3,7(pfeil hoch)) decane |
US5098929A (en) | 1985-07-30 | 1992-03-24 | The Wellcome Foundation Limited | Pesticidal compounds |
DE3627679A1 (de) | 1986-08-14 | 1988-02-25 | Blaupunkt Werke Gmbh | Filteranordnung |
FR2636061B1 (fr) * | 1988-09-07 | 1990-11-09 | Cird | Procede de preparation de derives de l'adamantane-1 |
FR2649976B1 (fr) * | 1989-07-20 | 1991-09-27 | Cird | Nouveau compose marque au tritium, sa preparation et son application notamment dans le reperage des recepteurs nucleaires des retinoides |
FR2676052B1 (fr) * | 1991-05-02 | 1994-04-29 | Cird Galderma | Nouveaux composes polycycliques aromatiques et leur utilisation en medecine humaine ou veterinaire et en cosmetique. |
US5770382A (en) | 1994-12-30 | 1998-06-23 | Ligand Pharmaceuticals, Inc. | Tricyclic retinoids, methods for their production and use |
EP0850067A4 (en) | 1995-07-17 | 1999-12-15 | Cird Galderma | METHOD FOR CANCER TREATMENT USING 6- (3- (1-ADAMANTYL) -4-HYDROXYPHENYL) 2 NAPHTALINE CARBONIC ACID |
FR2741876B1 (fr) | 1995-12-01 | 1998-01-09 | Cird Galderma | Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
ATE284213T1 (de) * | 1996-07-08 | 2004-12-15 | Galderma Res & Dev | Apoptose induzierende adamantyl-derivate und deren verwendung als antikrebsmittel |
US5888432A (en) | 1996-12-23 | 1999-03-30 | Corning Incorporated | 2-Adamantyl benzopyrans the compositions and (co)polymer matrices containing them |
US5919970A (en) | 1997-04-24 | 1999-07-06 | Allergan Sales, Inc. | Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity |
-
2000
- 2000-02-04 US US09/498,347 patent/US6462064B1/en not_active Expired - Fee Related
-
2001
- 2001-02-05 WO PCT/US2001/003717 patent/WO2001056563A1/en not_active Application Discontinuation
- 2001-02-05 JP JP2001556254A patent/JP2003521513A/ja not_active Withdrawn
- 2001-02-05 EP EP01908853A patent/EP1272176A4/en not_active Withdrawn
- 2001-02-05 AU AU2001236678A patent/AU2001236678A1/en not_active Abandoned
-
2002
- 2002-06-24 US US10/176,778 patent/US6825226B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1272176A4 (en) | 2004-12-29 |
US20030073745A1 (en) | 2003-04-17 |
WO2001056563A9 (en) | 2002-10-31 |
EP1272176A1 (en) | 2003-01-08 |
WO2001056563A1 (en) | 2001-08-09 |
JP2003521513A (ja) | 2003-07-15 |
US6825226B2 (en) | 2004-11-30 |
US6462064B1 (en) | 2002-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001236678A1 (en) | Adamantyl derivatives as anti-cancer agents | |
AU2001280099A1 (en) | 4-acylaminopyrazole derivatives | |
AU2001252463A1 (en) | Thiophene derivatives useful as anticancer agents | |
AU2001230584A1 (en) | 1h-imidazopyridine derivatives | |
GB0107758D0 (en) | Anti-cancer compounds | |
AU2002224595A1 (en) | Antitumor agents | |
AU2001230537A1 (en) | Pyridoxazine derivatives | |
AU2002224038A1 (en) | Benzimidazole derivatives | |
AU2001281802A1 (en) | 6-phenylpyrrolopyrimidinedione derivatives | |
AU2001278790A1 (en) | 1h-imidazopyridine derivatives | |
AU2001264280A1 (en) | Vitamin D derivatives | |
AU2001278694A1 (en) | Avermectin derivatives | |
AU2002213978A1 (en) | Substituted C-cyclohexylmethylamine derivatives | |
AU2002212301A1 (en) | Diazacycloalkanedione derivatives | |
AU4890301A (en) | 6-methylnicotinamide derivatives as antiviral agents | |
AU2002212959A1 (en) | Cycloalkylfluorosulfonamide derivatives | |
AU2001248777A1 (en) | Vitamin d derivatives | |
AU2002215212A1 (en) | 1-methylcarbapenem derivatives | |
AU2001289937A1 (en) | Substituted 1-aminobutan-3-ol derivatives | |
AU2001254661A1 (en) | Aminosulfonylbiphenyl derivatives | |
AU2001230565A1 (en) | Perfluoroisopropylbenzene derivatives | |
AU2001234313A1 (en) | Novel phenylheteroalkylamine derivatives | |
AU3430699A (en) | Butenolide derivatives as anti-cancer agents | |
AU2001242772A1 (en) | 3-substituted-4-pyrimidone derivatives | |
AU2001262489A1 (en) | Triterpenoid derivatives |